Vertex Pharmaceuticals Incorporated Share Price Sao Paulo
Stocks
VRTX34
BRVRTXBDR001
Pharmaceuticals
|
Market Closed -
Sao Paulo
20:29:53 29/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 85.86 BRL | -0.42% |
|
+3.90% | +9.74% |
| 09-28 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 09-23 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
| Market Cap | 134B 700B 118B 112B 101B 190B 12,834B 192B 1,340B 516B 6,553B 502B 491B 21,089B | P/E 2026 * |
54.1x | P/E 2027 * | 28.5x |
|---|---|---|---|---|---|
| Enterprise Value | 128B 671B 113B 107B 97.08B 182B 12,302B 184B 1,284B 495B 6,282B 481B 471B 20,215B | EV / Sales 2026 * |
9.68x | EV / Sales 2027 * | 8.53x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -0.42% | ||
| 1 week | +3.90% | ||
| Current month | -2.35% | ||
| 1 month | -2.35% | ||
| 3 months | +1.33% | ||
| 6 months | +18.66% | ||
| Current year | +9.74% |
| 1 week | 81.3 |  | 86.22 |
| 1 month | 80.64 | | 88.92 |
| Current year | 65.18 | | 89.01 |
| 1 year | 65.18 | | 89.01 |
| 3 years | 52.29 | | 93.56 |
| 5 years | 30.22 | | 93.56 |
| 10 years | 20.29 | | 93.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 31/03/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 09/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 31/12/1997 |
Jeffrey Leiden
CHM | Chairman | 70 | 30/04/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 17/06/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | +3.90% | - | - | 134B | |
| -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | |
| -1.61% | -0.60% | +47.32% | +71.79% | 655B | |
| -1.12% | -0.72% | +17.98% | +76.63% | 471B | |
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | |
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | |
| -0.51% | -1.05% | +12.98% | +12.92% | 257B | |
| +1.32% | +3.27% | +54.63% | +57.63% | 226B | |
| -0.61% | -0.91% | +34.33% | +101.87% | 189B | |
| -0.24% | -3.21% | -27.79% | -61.37% | 170B | |
| Average | -0.21% | +0.97% | +29.00% | +49.81% | 404.77B | |
| Weighted average by Cap. | -0.06% | +1.04% | +39.01% | +70.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.25B 69.37B 11.69B 11.06B 10.03B 18.81B 1,271B 18.99B 133B 51.14B 649B 49.75B 48.66B 2,089B | 14.55B 76.19B 12.84B 12.15B 11.02B 20.66B 1,396B 20.86B 146B 56.17B 713B 54.64B 53.45B 2,294B |
| Net income | 2.54B 13.28B 2.24B 2.12B 1.92B 3.6B 243B 3.64B 25.4B 9.79B 124B 9.52B 9.31B 400B | 4.84B 25.32B 4.27B 4.04B 3.66B 6.87B 464B 6.93B 48.44B 18.67B 237B 18.16B 17.77B 763B |
| Net Debt | -5.54B -29.02B -4.89B -4.63B -4.2B -7.87B -532B -7.95B -55.52B -21.4B -272B -20.81B -20.36B -874B | -9.58B -50.16B -8.45B -8B -7.25B -13.6B -919B -13.73B -95.95B -36.98B -469B -35.97B -35.19B -1,510B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | R$85.86 | -0.42% | 611 |
| 28/09/26 | R$86.22 | +1.41% | 6 |
| 24/09/26 | R$85.02 | +2.48% | 169 |
| 23/09/26 | R$82.96 | +0.39% | 33 |
| 22/09/26 | R$82.64 | +1.37% | 4 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
Select your edition
All financial news and data tailored to specific country editions
